Literature DB >> 23222246

Tissue microarray technology and findings for diagnostic immunohistochemistry.

Anthony van Zwieten1.   

Abstract

AIMS: This study was undertaken to determine the validity and viability of tissue microarray (TMA) technology in assessing diagnostic immunohistochemistry (IHC) at a single laboratory site.
METHODS: IHC using 57 primary antibodies was performed on a TMA paraffin block containing 89 cores of duplicate previously identified 1 mm diameter tissue specimens. IHC was interpreted by a histology scientist with IHC experience, with pathologist assistance if required. Review of the literature was performed to investigate cases of unexpected immunoreactivity.
RESULTS: 55 of 57 antibodies had expected positive staining against the TMA tissue panel that correlated with the original paraffin blocks. Immunostaining of duplicate 1 mm cores correlated with the originally sourced paraffin block in 42 of 43 (98%) tissue types. Some antibodies had unexpected positive immunoreactivity. DISCUSSION: TMA technology can be utilised effectively in the diagnostic IHC laboratory as a universal positive multiple tissue control block for routine IHC, and can provide valuable information for the benefit of histology scientists and pathologists with respect to interpretation of IHC staining.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23222246     DOI: 10.1097/PAT.0b013e32835b7b99

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  3 in total

1.  Expression of prolyl 4-hydroxylase beta-polypeptide in non-small cell lung cancer treated with Chinese medicines.

Authors:  Shu-mei Wang; Li-zhu Lin; Dai-han Zhou; Jing-xu Zhou; Shao-quan Xiong
Journal:  Chin J Integr Med       Date:  2014-01-02       Impact factor: 1.978

2.  The Novel Tumor Microenvironment-Related Prognostic Gene AIF1 May Influence Immune Infiltrates and is Correlated with TIGIT in Esophageal Cancer.

Authors:  Xiaoling Xu; Ding Wang; Na Li; Jiamin Sheng; Mingying Xie; Zichao Zhou; Guoping Cheng; Yun Fan
Journal:  Ann Surg Oncol       Date:  2021-11-09       Impact factor: 4.339

3.  A molecular approach combined with American Thyroid Association classification better stratifies recurrence risk of classic histology papillary thyroid cancer.

Authors:  Alexander J Lin; Pamela Samson; Todd DeWees; Lauren Henke; Thomas Baranski; Julie Schwarz; John Pfeifer; Perry Grigsby; Stephanie Markovina
Journal:  Cancer Med       Date:  2018-12-14       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.